Literature DB >> 22534002

Silicosis.

Chi Chiu Leung1, Ignatius Tak Sun Yu, Weihong Chen.   

Abstract

Silicosis is a fibrotic lung disease caused by inhalation of free crystalline silicon dioxide or silica. Occupational exposure to respirable crystalline silica dust particles occurs in many industries. Phagocytosis of crystalline silica in the lung causes lysosomal damage, activating the NALP3 inflammasome and triggering the inflammatory cascade with subsequent fibrosis. Impairment of lung function increases with disease progression, even after the patient is no longer exposed. Diagnosis of silicosis needs carefully documented records of occupational exposure and radiological features, with exclusion of other competing diagnoses. Mycobacterial diseases, airway obstruction, and lung cancer are associated with silica dust exposure. As yet, no curative treatment exists, but comprehensive management strategies help to improve quality of life and slow deterioration. Further efforts are needed for recognition and control of silica hazards, especially in developing countries.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22534002     DOI: 10.1016/S0140-6736(12)60235-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  266 in total

Review 1.  The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis.

Authors:  José A Gómez-Puerta; Lydia Gedmintas; Karen H Costenbader
Journal:  Autoimmun Rev       Date:  2013-06-29       Impact factor: 9.754

2.  MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2.

Authors:  Ruhui Han; Xiaoming Ji; Rong Rong; Yan Li; Wenxi Yao; Jiali Yuan; Qiuyun Wu; Jingjin Yang; Weiwen Yan; Lei Han; Baoli Zhu; Chunhui Ni
Journal:  J Mol Med (Berl)       Date:  2016-06-28       Impact factor: 4.599

3.  Inflammasome Activity in Non-Microbial Lung Inflammation.

Authors:  Jennifer L Ather; Rebecca A Martin; Karina Ckless; Matthew E Poynter
Journal:  J Environ Immunol Toxicol       Date:  2014-09-20

4.  Characterizing Particle Size Distributions of Crystalline Silica in Gold Mine Dust.

Authors:  Lauren G Chubb; Emanuele G Cauda
Journal:  Aerosol Air Qual Res       Date:  2017-01       Impact factor: 3.063

5.  Prevention of crystalline silica-induced inflammation by the anti-malarial hydroxychloroquine.

Authors:  Rachel Burmeister; Joseph F Rhoderick; Andrij Holian
Journal:  Inhal Toxicol       Date:  2019-09-26       Impact factor: 2.724

6.  The effects of barium concentration levels on the pulmonary inflammatory response in a rat model of aspiration.

Authors:  Rumi Ueha; Nogah Nativ-Zeltzer; Taku Sato; Takao Goto; Akihito Yamauchi; Peter C Belafsky; Tatsuya Yamasoba
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-25       Impact factor: 2.503

7.  Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis.

Authors:  Christian Bode; Takeshi Kinjo; W Gregory Alvord; Dennis M Klinman
Journal:  Carcinogenesis       Date:  2014-01-08       Impact factor: 4.944

8.  Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition.

Authors:  Rosana Gonzalez-Quintial; Jessica M Mayeux; Dwight H Kono; Argyrios N Theofilopoulos; Kenneth M Pollard; Roberto Baccala
Journal:  Clin Immunol       Date:  2019-06-05       Impact factor: 3.969

9.  Outbreak of silicosis in Spanish quartz conglomerate workers.

Authors:  Aránzazu Pérez-Alonso; Juan Antonio Córdoba-Doña; José Luis Millares-Lorenzo; Estrella Figueroa-Murillo; Cristina García-Vadillo; José Romero-Morillos
Journal:  Int J Occup Environ Health       Date:  2014 Jan-Mar

10.  Exposure of patient and dental staff to fine and ultrafine particles from scanning spray.

Authors:  Stefan Rupf; Hendrik Berger; Axel Buchter; Volker Harth; Mei Fang Ong; Matthias Hannig
Journal:  Clin Oral Investig       Date:  2014-08-07       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.